Global Ophthalmology Drugs Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

November 2018 | 117 pages | ID: GD239B27C32EN
GlobalInfoResearch

Abstracts

Ophthalmology is a broad therapy area that consists of almost 100 disorders associated with the eyes and visual system, including such diseases as glaucoma, age-related macular degeneration (AMD), diabetic macular edema (DME), diabetic retinopathy (DR) and dry eye syndrome (DES). Many of these disorders are progressive, and if left untreated can lead to severe visual impairment or even blindness.

Scope of the Report:

Of the five key indications within the therapy area - glaucoma, AMD, DME, DR and DES - glaucoma and AMD have the most active product pipelines.

The global Ophthalmology Drugs market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.

The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.

North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Ophthalmology Drugs.

Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.

This report studies the Ophthalmology Drugs market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Ophthalmology Drugs market by product type and applications/end industries.

Market Segment by Companies, this report covers

• Novartis
• Regeneron
• Roche
• Bayer
• Allergan
• Shire
• Mallinckrodt
• Santen Pharmaceutical 
• Aerie

Market Segment by Regions, regional analysis covers

• North America (United States, Canada and Mexico)
• Europe (Germany, France, UK, Russia and Italy)
• Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
• South America (Brazil, Argentina, Colombia)
• Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

• Lucentis (Ranibizumab)
• Eylea (Aflibercept)
• Avastin (Bevacizumab)
• Restasis (Cyclosporine)
• Alphagan (Brimonidine Tartrate)
• Lumigan (Bimatoprost)
• Xalatan (Latanoprost)
• Conclusion

Market Segment by Applications, can be divided into

• Hospital Pharmacies
• Retail Pharmacies
• Drug Stores
• Online Sales

Contents

1 OPHTHALMOLOGY DRUGS MARKET OVERVIEW

1.1 Product Overview and Scope of Ophthalmology Drugs
1.2 Classification of Ophthalmology Drugs by Types
  1.2.1 Global Ophthalmology Drugs Revenue Comparison by Types (2017-2023)
  1.2.2 Global Ophthalmology Drugs Revenue Market Share by Types in 2017
  1.2.3 Lucentis (Ranibizumab)
  1.2.4 Eylea (Aflibercept)
  1.2.5 Avastin (Bevacizumab)
  1.2.6 Restasis (Cyclosporine)
  1.2.7 Alphagan (Brimonidine Tartrate)
  1.2.8 Lumigan (Bimatoprost)
  1.2.9 Xalatan (Latanoprost)
  1.2.10 Conclusion
1.3 Global Ophthalmology Drugs Market by Application
  1.3.1 Global Ophthalmology Drugs Market Size and Market Share Comparison by Applications (2013-2023)
  1.3.2 Hospital Pharmacies
  1.3.3 Retail Pharmacies
  1.3.4 Drug Stores
  1.3.5 Online Sales
1.4 Global Ophthalmology Drugs Market by Regions
  1.4.1 Global Ophthalmology Drugs Market Size (Million USD) Comparison by Regions (2013-2023)
  1.4.1 North America (USA, Canada and Mexico) Ophthalmology Drugs Status and Prospect (2013-2023)
  1.4.2 Europe (Germany, France, UK, Russia and Italy) Ophthalmology Drugs Status and Prospect (2013-2023)
  1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Ophthalmology Drugs Status and Prospect (2013-2023)
  1.4.4 South America (Brazil, Argentina, Colombia) Ophthalmology Drugs Status and Prospect (2013-2023)
  1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Ophthalmology Drugs Status and Prospect (2013-2023)
1.5 Global Market Size of Ophthalmology Drugs (2013-2023)

2 MANUFACTURERS PROFILES

2.1 Novartis
  2.1.1 Business Overview
  2.1.2 Ophthalmology Drugs Type and Applications
    2.1.2.1 Product A
    2.1.2.2 Product B
  2.1.3 Novartis Ophthalmology Drugs Revenue, Gross Margin and Market Share (2016-2017)
2.2 Regeneron
  2.2.1 Business Overview
  2.2.2 Ophthalmology Drugs Type and Applications
    2.2.2.1 Product A
    2.2.2.2 Product B
  2.2.3 Regeneron Ophthalmology Drugs Revenue, Gross Margin and Market Share (2016-2017)
2.3 Roche
  2.3.1 Business Overview
  2.3.2 Ophthalmology Drugs Type and Applications
    2.3.2.1 Product A
    2.3.2.2 Product B
  2.3.3 Roche Ophthalmology Drugs Revenue, Gross Margin and Market Share (2016-2017)
2.4 Bayer
  2.4.1 Business Overview
  2.4.2 Ophthalmology Drugs Type and Applications
    2.4.2.1 Product A
    2.4.2.2 Product B
  2.4.3 Bayer Ophthalmology Drugs Revenue, Gross Margin and Market Share (2016-2017)
2.5 Allergan
  2.5.1 Business Overview
  2.5.2 Ophthalmology Drugs Type and Applications
    2.5.2.1 Product A
    2.5.2.2 Product B
  2.5.3 Allergan Ophthalmology Drugs Revenue, Gross Margin and Market Share (2016-2017)
2.6 Shire
  2.6.1 Business Overview
  2.6.2 Ophthalmology Drugs Type and Applications
    2.6.2.1 Product A
    2.6.2.2 Product B
  2.6.3 Shire Ophthalmology Drugs Revenue, Gross Margin and Market Share (2016-2017)
2.7 Mallinckrodt
  2.7.1 Business Overview
  2.7.2 Ophthalmology Drugs Type and Applications
    2.7.2.1 Product A
    2.7.2.2 Product B
  2.7.3 Mallinckrodt Ophthalmology Drugs Revenue, Gross Margin and Market Share (2016-2017)
2.8 Santen Pharmaceutical
  2.8.1 Business Overview
  2.8.2 Ophthalmology Drugs Type and Applications
    2.8.2.1 Product A
    2.8.2.2 Product B
  2.8.3 Santen Pharmaceutical Ophthalmology Drugs Revenue, Gross Margin and Market Share (2016-2017)
2.9 Aerie
  2.9.1 Business Overview
  2.9.2 Ophthalmology Drugs Type and Applications
    2.9.2.1 Product A
    2.9.2.2 Product B
  2.9.3 Aerie Ophthalmology Drugs Revenue, Gross Margin and Market Share (2016-2017)

3 GLOBAL OPHTHALMOLOGY DRUGS MARKET COMPETITION, BY PLAYERS

3.1 Global Ophthalmology Drugs Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
  3.2.1 Top 5 Ophthalmology Drugs Players Market Share
  3.2.2 Top 10 Ophthalmology Drugs Players Market Share
3.3 Market Competition Trend

4 GLOBAL OPHTHALMOLOGY DRUGS MARKET SIZE BY REGIONS

4.1 Global Ophthalmology Drugs Revenue and Market Share by Regions
4.2 North America Ophthalmology Drugs Revenue and Growth Rate (2013-2018)
4.3 Europe Ophthalmology Drugs Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Ophthalmology Drugs Revenue and Growth Rate (2013-2018)
4.5 South America Ophthalmology Drugs Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Ophthalmology Drugs Revenue and Growth Rate (2013-2018)

5 NORTH AMERICA OPHTHALMOLOGY DRUGS REVENUE BY COUNTRIES

5.1 North America Ophthalmology Drugs Revenue by Countries (2013-2018)
5.2 USA Ophthalmology Drugs Revenue and Growth Rate (2013-2018)
5.3 Canada Ophthalmology Drugs Revenue and Growth Rate (2013-2018)
5.4 Mexico Ophthalmology Drugs Revenue and Growth Rate (2013-2018)

6 EUROPE OPHTHALMOLOGY DRUGS REVENUE BY COUNTRIES

6.1 Europe Ophthalmology Drugs Revenue by Countries (2013-2018)
6.2 Germany Ophthalmology Drugs Revenue and Growth Rate (2013-2018)
6.3 UK Ophthalmology Drugs Revenue and Growth Rate (2013-2018)
6.4 France Ophthalmology Drugs Revenue and Growth Rate (2013-2018)
6.5 Russia Ophthalmology Drugs Revenue and Growth Rate (2013-2018)
6.6 Italy Ophthalmology Drugs Revenue and Growth Rate (2013-2018)

7 ASIA-PACIFIC OPHTHALMOLOGY DRUGS REVENUE BY COUNTRIES

7.1 Asia-Pacific Ophthalmology Drugs Revenue by Countries (2013-2018)
7.2 China Ophthalmology Drugs Revenue and Growth Rate (2013-2018)
7.3 Japan Ophthalmology Drugs Revenue and Growth Rate (2013-2018)
7.4 Korea Ophthalmology Drugs Revenue and Growth Rate (2013-2018)
7.5 India Ophthalmology Drugs Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Ophthalmology Drugs Revenue and Growth Rate (2013-2018)

8 SOUTH AMERICA OPHTHALMOLOGY DRUGS REVENUE BY COUNTRIES

8.1 South America Ophthalmology Drugs Revenue by Countries (2013-2018)
8.2 Brazil Ophthalmology Drugs Revenue and Growth Rate (2013-2018)
8.3 Argentina Ophthalmology Drugs Revenue and Growth Rate (2013-2018)
8.4 Colombia Ophthalmology Drugs Revenue and Growth Rate (2013-2018)

9 MIDDLE EAST AND AFRICA REVENUE OPHTHALMOLOGY DRUGS BY COUNTRIES

9.1 Middle East and Africa Ophthalmology Drugs Revenue by Countries (2013-2018)
9.2 Saudi Arabia Ophthalmology Drugs Revenue and Growth Rate (2013-2018)
9.3 UAE Ophthalmology Drugs Revenue and Growth Rate (2013-2018)
9.4 Egypt Ophthalmology Drugs Revenue and Growth Rate (2013-2018)
9.5 Nigeria Ophthalmology Drugs Revenue and Growth Rate (2013-2018)
9.6 South Africa Ophthalmology Drugs Revenue and Growth Rate (2013-2018)

10 GLOBAL OPHTHALMOLOGY DRUGS MARKET SEGMENT BY TYPE

10.1 Global Ophthalmology Drugs Revenue and Market Share by Type (2013-2018)
10.2 Global Ophthalmology Drugs Market Forecast by Type (2018-2023)
10.3 Lucentis (Ranibizumab) Revenue Growth Rate (2013-2023)
10.4 Eylea (Aflibercept) Revenue Growth Rate (2013-2023)
10.5 Avastin (Bevacizumab) Revenue Growth Rate (2013-2023)
10.6 Restasis (Cyclosporine) Revenue Growth Rate (2013-2023)
10.7 Alphagan (Brimonidine Tartrate) Revenue Growth Rate (2013-2023)
10.8 Lumigan (Bimatoprost) Revenue Growth Rate (2013-2023)
10.9 Xalatan (Latanoprost) Revenue Growth Rate (2013-2023)
10.10 Conclusion Revenue Growth Rate (2013-2023)

11 GLOBAL OPHTHALMOLOGY DRUGS MARKET SEGMENT BY APPLICATION

11.1 Global Ophthalmology Drugs Revenue Market Share by Application (2013-2018)
11.2 Ophthalmology Drugs Market Forecast by Application (2018-2023)
11.3 Hospital Pharmacies Revenue Growth (2013-2018)
11.4 Retail Pharmacies Revenue Growth (2013-2018)
11.5 Drug Stores Revenue Growth (2013-2018)
11.6 Online Sales Revenue Growth (2013-2018)

12 GLOBAL OPHTHALMOLOGY DRUGS MARKET SIZE FORECAST (2018-2023)

12.1 Global Ophthalmology Drugs Market Size Forecast (2018-2023)
12.2 Global Ophthalmology Drugs Market Forecast by Regions (2018-2023)
12.3 North America Ophthalmology Drugs Revenue Market Forecast (2018-2023)
12.4 Europe Ophthalmology Drugs Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Ophthalmology Drugs Revenue Market Forecast (2018-2023)
12.6 South America Ophthalmology Drugs Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Ophthalmology Drugs Revenue Market Forecast (2018-2023)

13 RESEARCH FINDINGS AND CONCLUSION

14 APPENDIX

14.1 Methodology
14.2 Data Source

List Of Tables

LIST OF TABLES AND FIGURES

Figure Ophthalmology Drugs Picture
Table Product Specifications of Ophthalmology Drugs
Table Global Ophthalmology Drugs and Revenue (Million USD) Market Split by Product Type
Figure Global Ophthalmology Drugs Revenue Market Share by Types in 2017
Figure Lucentis (Ranibizumab) Picture
Figure Eylea (Aflibercept) Picture
Figure Avastin (Bevacizumab) Picture
Figure Restasis (Cyclosporine) Picture
Figure Alphagan (Brimonidine Tartrate) Picture
Figure Lumigan (Bimatoprost) Picture
Figure Xalatan (Latanoprost) Picture
Figure Conclusion Picture
Table Global Ophthalmology Drugs Revenue (Million USD) by Application (2013-2023)
Figure Ophthalmology Drugs Revenue Market Share by Applications in 2017
Figure Hospital Pharmacies Picture
Figure Retail Pharmacies Picture
Figure Drug Stores Picture
Figure Online Sales Picture
Table Global Market Ophthalmology Drugs Revenue (Million USD) Comparison by Regions 2013-2023
Figure North America Ophthalmology Drugs Revenue (Million USD) and Growth Rate (2013-2023)
Figure Europe Ophthalmology Drugs Revenue (Million USD) and Growth Rate (2013-2023)
Figure Asia-Pacific Ophthalmology Drugs Revenue (Million USD) and Growth Rate (2013-2023)
Figure South America Ophthalmology Drugs Revenue (Million USD) and Growth Rate (2013-2023)
Figure Middle East and Africa Ophthalmology Drugs Revenue (Million USD) and Growth Rate (2013-2023)
Figure Global Ophthalmology Drugs Revenue (Million USD) and Growth Rate (2013-2023)
Table Novartis Basic Information, Manufacturing Base and Competitors
Table Novartis Ophthalmology Drugs Type and Applications
Table Novartis Ophthalmology Drugs Revenue, Gross Margin and Market Share (2016-2017)
Table Regeneron Basic Information, Manufacturing Base and Competitors
Table Regeneron Ophthalmology Drugs Type and Applications
Table Regeneron Ophthalmology Drugs Revenue, Gross Margin and Market Share (2016-2017)
Table Roche Basic Information, Manufacturing Base and Competitors
Table Roche Ophthalmology Drugs Type and Applications
Table Roche Ophthalmology Drugs Revenue, Gross Margin and Market Share (2016-2017)
Table Bayer Basic Information, Manufacturing Base and Competitors
Table Bayer Ophthalmology Drugs Type and Applications
Table Bayer Ophthalmology Drugs Revenue, Gross Margin and Market Share (2016-2017)
Table Allergan Basic Information, Manufacturing Base and Competitors
Table Allergan Ophthalmology Drugs Type and Applications
Table Allergan Ophthalmology Drugs Revenue, Gross Margin and Market Share (2016-2017)
Table Shire Basic Information, Manufacturing Base and Competitors
Table Shire Ophthalmology Drugs Type and Applications
Table Shire Ophthalmology Drugs Revenue, Gross Margin and Market Share (2016-2017)
Table Mallinckrodt Basic Information, Manufacturing Base and Competitors
Table Mallinckrodt Ophthalmology Drugs Type and Applications
Table Mallinckrodt Ophthalmology Drugs Revenue, Gross Margin and Market Share (2016-2017)
Table Santen Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table Santen Pharmaceutical Ophthalmology Drugs Type and Applications
Table Santen Pharmaceutical Ophthalmology Drugs Revenue, Gross Margin and Market Share (2016-2017)
Table Aerie Basic Information, Manufacturing Base and Competitors
Table Aerie Ophthalmology Drugs Type and Applications
Table Aerie Ophthalmology Drugs Revenue, Gross Margin and Market Share (2016-2017)
Table Global Ophthalmology Drugs Revenue (Million USD) by Players (2013-2018)
Table Global Ophthalmology Drugs Revenue Share by Players (2013-2018)
Figure Global Ophthalmology Drugs Revenue Share by Players in 2016
Figure Global Ophthalmology Drugs Revenue Share by Players in 2017
Figure Global Top 5 Players Ophthalmology Drugs Revenue Market Share in 2017
Figure Global Top 10 Players Ophthalmology Drugs Revenue Market Share in 2017
Figure Global Ophthalmology Drugs Revenue (Million USD) and Growth Rate (%) (2013-2018)
Table Global Ophthalmology Drugs Revenue (Million USD) by Regions (2013-2018)
Table Global Ophthalmology Drugs Revenue Market Share by Regions (2013-2018)
Figure Global Ophthalmology Drugs Revenue Market Share by Regions (2013-2018)
Figure Global Ophthalmology Drugs Revenue Market Share by Regions in 2017
Figure North America Ophthalmology Drugs Revenue and Growth Rate (2013-2018)
Figure Europe Ophthalmology Drugs Revenue and Growth Rate (2013-2018)
Figure Asia-Pacific Ophthalmology Drugs Revenue and Growth Rate (2013-2018)
Figure South America Ophthalmology Drugs Revenue and Growth Rate (2013-2018)
Figure Middle East and Africa Ophthalmology Drugs Revenue and Growth Rate (2013-2018)
Table North America Ophthalmology Drugs Revenue by Countries (2013-2018)
Table North America Ophthalmology Drugs Revenue Market Share by Countries (2013-2018)
Figure North America Ophthalmology Drugs Revenue Market Share by Countries (2013-2018)
Figure North America Ophthalmology Drugs Revenue Market Share by Countries in 2017
Figure USA Ophthalmology Drugs Revenue and Growth Rate (2013-2018)
Figure Canada Ophthalmology Drugs Revenue and Growth Rate (2013-2018)
Figure Mexico Ophthalmology Drugs Revenue and Growth Rate (2013-2018)
Table Europe Ophthalmology Drugs Revenue (Million USD) by Countries (2013-2018)
Figure Europe Ophthalmology Drugs Revenue Market Share by Countries (2013-2018)
Figure Europe Ophthalmology Drugs Revenue Market Share by Countries in 2017
Figure Germany Ophthalmology Drugs Revenue and Growth Rate (2013-2018)
Figure UK Ophthalmology Drugs Revenue and Growth Rate (2013-2018)
Figure France Ophthalmology Drugs Revenue and Growth Rate (2013-2018)
Figure Russia Ophthalmology Drugs Revenue and Growth Rate (2013-2018)
Figure Italy Ophthalmology Drugs Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Ophthalmology Drugs Revenue (Million USD) by Countries (2013-2018)
Figure Asia-Pacific Ophthalmology Drugs Revenue Market Share by Countries (2013-2018)
Figure Asia-Pacific Ophthalmology Drugs Revenue Market Share by Countries in 2017
Figure China Ophthalmology Drugs Revenue and Growth Rate (2013-2018)
Figure Japan Ophthalmology Drugs Revenue and Growth Rate (2013-2018)
Figure Korea Ophthalmology Drugs Revenue and Growth Rate (2013-2018)
Figure India Ophthalmology Drugs Revenue and Growth Rate (2013-2018)
Figure Southeast Asia Ophthalmology Drugs Revenue and Growth Rate (2013-2018)
Table South America Ophthalmology Drugs Revenue by Countries (2013-2018)
Table South America Ophthalmology Drugs Revenue Market Share by Countries (2013-2018)
Figure South America Ophthalmology Drugs Revenue Market Share by Countries (2013-2018)
Figure South America Ophthalmology Drugs Revenue Market Share by Countries in 2017
Figure Brazil Ophthalmology Drugs Revenue and Growth Rate (2013-2018)
Figure Argentina Ophthalmology Drugs Revenue and Growth Rate (2013-2018)
Figure Colombia Ophthalmology Drugs Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Ophthalmology Drugs Revenue (Million USD) by Countries (2013-2018)
Table Middle East and Africa Ophthalmology Drugs Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Ophthalmology Drugs Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Ophthalmology Drugs Revenue Market Share by Countries in 2017
Figure Saudi Arabia Ophthalmology Drugs Revenue and Growth Rate (2013-2018)
Figure UAE Ophthalmology Drugs Revenue and Growth Rate (2013-2018)
Figure Egypt Ophthalmology Drugs Revenue and Growth Rate (2013-2018)
Figure Nigeria Ophthalmology Drugs Revenue and Growth Rate (2013-2018)
Figure South Africa Ophthalmology Drugs Revenue and Growth Rate (2013-2018)
Table Global Ophthalmology Drugs Revenue (Million USD) by Type (2013-2018)
Table Global Ophthalmology Drugs Revenue Share by Type (2013-2018)
Figure Global Ophthalmology Drugs Revenue Share by Type (2013-2018)
Figure Global Ophthalmology Drugs Revenue Share by Type in 2017
Table Global Ophthalmology Drugs Revenue Forecast by Type (2018-2023)
Figure Global Ophthalmology Drugs Market Share Forecast by Type (2018-2023)
Figure Global Lucentis (Ranibizumab) Revenue Growth Rate (2013-2018)
Figure Global Eylea (Aflibercept) Revenue Growth Rate (2013-2018)
Figure Global Avastin (Bevacizumab) Revenue Growth Rate (2013-2018)
Figure Global Restasis (Cyclosporine) Revenue Growth Rate (2013-2018)
Figure Global Alphagan (Brimonidine Tartrate) Revenue Growth Rate (2013-2018)
Figure Global Lumigan (Bimatoprost) Revenue Growth Rate (2013-2018)
Figure Global Xalatan (Latanoprost) Revenue Growth Rate (2013-2018)
Figure Global Conclusion Revenue Growth Rate (2013-2018)
Table Global Ophthalmology Drugs Revenue by Application (2013-2018)
Table Global Ophthalmology Drugs Revenue Share by Application (2013-2018)
Figure Global Ophthalmology Drugs Revenue Share by Application (2013-2018)
Figure Global Ophthalmology Drugs Revenue Share by Application in 2017
Table Global Ophthalmology Drugs Revenue Forecast by Application (2018-2023)
Figure Global Ophthalmology Drugs Market Share Forecast by Application (2018-2023)
Figure Global Hospital Pharmacies Revenue Growth Rate (2013-2018)
Figure Global Retail Pharmacies Revenue Growth Rate (2013-2018)
Figure Global Drug Stores Revenue Growth Rate (2013-2018)
Figure Global Online Sales Revenue Growth Rate (2013-2018)
Figure Global Ophthalmology Drugs Revenue (Million USD) and Growth Rate Forecast (2018 -2023)
Table Global Ophthalmology Drugs Revenue (Million USD) Forecast by Regions (2018-2023)
Figure Global Ophthalmology Drugs Revenue Market Share Forecast by Regions (2018-2023)
Figure North America Ophthalmology Drugs Revenue Market Forecast (2018-2023)
Figure Europe Ophthalmology Drugs Revenue Market Forecast (2018-2023)
Figure Asia-Pacific Ophthalmology Drugs Revenue Market Forecast (2018-2023)
Figure South America Ophthalmology Drugs Revenue Market Forecast (2018-2023)
Figure Middle East and Africa Ophthalmology Drugs Revenue Market Forecast (2018-2023)